Close Menu

Enzo

Roche, Life Technologies, and Gen-Probe have each filed responses to a lawsuit brought against them by Enzo Life Sciences claiming that various nucleic acid probe-based research and diagnostics products infringe a patent owned by Enzo.

NEW YORK (GenomeWeb News) – Enzo Biochem has issued 275,000 shares of its common stock to its law firm as payment for legal fees, the New York-based company disclosed in a document filed on Friday with the US Securities and Exchange Commission.

NEW YORK (GenomeWeb News) – Enzo Biochem reported after the close of the market on Monday that revenues for the fiscal third quarter inched up slightly year over year, but that net loss increased.

Quest Diagnostics has introduced its Thyroglobulin Post-treatment Monitoring Test for monitoring recurrence of thyroid cancer following surgery.

Austin Breast Center Offers BrevaGen Breast Cancer Risk Dx

PerkinElmer of Waltham, Mass., has received US Patent No.

NEW YORK (GenomeWeb News) – Enzo Biochem today said that its Enzo Life Sciences subsidiary has expanded a distribution agreement with Tokyo-based Cosmo Bio.

This story has been updated from a previously posted version.
Enzo Diagnostics has been awarded US Patent No. 8,133,989, "Nucleic acid primer/construct compositions."

Pages

Researchers are developing a breath test to determine how severe patients' methylmalonic acidemia disease is, FierceBiotech reports.

NPR reports that vaccine developers are working on SARS-CoV-2 vaccines that are easier to store or administer than the current crop.

Reuters reports that France is to recommend that people under 55 who received one dose of AstraZeneca's SARS-CoV-2 vaccine receive a different vaccine for their second dose.